Vienna
Austria
26
2011-08-04
24
2013-04-23
These are the the leading inventors for applications assigned to Baxter Aktiengesellschaft:
Baxter Aktiengesellschaft based in Vienna, AT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Fibrinogen-based tissue adhesive containing an elastase inhibitor
#2 | 2011-05-05 ✅ Patent 8,329,465 granted on 2012-12-11Recombinant cell clones having increased stability and methods of making and using the same
#3 | 2010-12-16 ✅ Patent 8,084,252 granted on 2011-12-27Recombinant cell clones having increased stability and methods of making and using the same
#4 | 2010-09-02 ✅ Patent 8,084,251 granted on 2011-12-27Recombinant cell clones having increased stability and methods of making and using the same
#5 | 2009-10-15RECOMBINANT CELL CLONES HAVING INCREASED STABILITY AND METHODS OF MAKING AND USING SAME
#6 | 2009-10-08 ✅ Patent 8,080,414 granted on 2011-12-20Recombinant cell clones having increased stability and methods of making and using the same
#7 | 2009-02-12 ✅ Patent 7,892,802 granted on 2011-02-22Fibrinogen-based tissue adhesive containing an elastase inhibitor
#8 | 2008-07-31 ✅ Patent 8,021,881 granted on 2011-09-20Medium for the protein-free and serum-free cultivation of cells
#9 | 2008-07-24 ✅ Patent 8,703,426 granted on 2014-04-22Composition exhibiting a von Willebrand Factor (vWF) protease activity with the amino acid sequence AAGGILHLELLV
#10 | 2007-07-12Recombinant cell clones having increased stability and methods of making and using the same
#11 | 2007-07-10 ✅ Patent 7,241,603 granted on 2007-07-10Method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
#12 | 2007-05-22 ✅ Patent 7,220,569 granted on 2007-05-22Nucleic acids encoding factor X analogues having a modified protease cleavage site
#13 | 2006-09-28 ✅ Patent 7,459,295 granted on 2008-12-02Fibrinogen-based tissue adhesive containing an elastase inhibitor
#14 | 2006-08-15 ✅ Patent 7,091,015 granted on 2006-08-15Fibrinogen-based tissue adhesive
#15 | 2006-07-20 ✅ Patent 7,544,660 granted on 2009-06-09Factor VIII polypeptide having factor VIII:C activity
#16 | 2006-04-25 ✅ Patent 7,033,590 granted on 2006-04-25Factor IX/factor IXa activating antibodies and antibody derivatives
#17 | 2006-01-05 ✅ Patent 7,557,188 granted on 2009-07-07Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptide
#18 | 2005-10-27 ✅ Patent 7,648,958 granted on 2010-01-19Factor VIII/vWF-complex and methods of purifying same
#19 | 2005-10-25 ✅ Patent 6,958,322 granted on 2005-10-25Factor X analog with an improved ability to be activated
#20 | 2005-10-11 ✅ Patent 6,953,837 granted on 2005-10-11Factor VIII/vWF complexes and compositions
#21 | 2005-09-22 ✅ Patent 7,498,146 granted on 2009-03-03Stable factor VIII/von willebrand factor complex
#22 | 2005-09-08 ✅ Patent 7,094,574 granted on 2006-08-22Recombinant cell clones having increased stability and methods of making and using the same
#23 | 2005-09-08 ✅ Patent 7,279,161 granted on 2007-10-09Factor IX/factor IXa activating antibodies and antibody derivatives
#24 | 2005-08-30 ✅ Patent 6,936,441 granted on 2005-08-30Recombinant cell clones having increased stability and methods of making and using the same
#25 | 2005-08-09 ✅ Patent 6,926,894 granted on 2005-08-09Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
#26 | 2005-06-14 ✅ Patent 6,905,846 granted on 2005-06-14Nucleic acids encoding factor X deletion mutants and analogues thereof
200441 ⎘